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Q1Epoxy–amine oligomers from terpenes with
applications in synergistic antifungal treatments†
Dara M. O’Brien, a Cindy Vallieres,b Cameron Alexander, c
Steven M. Howdle, a Robert A. Stockman *a and Simon V. Avery*b
A bis-epoxide monomer was synthesised in two steps from (R)-carvone, a terpenoid renewable
feedstock derived from spearmint oil, and used to prepare b-aminoalcohol oligomers in polyaddition
reactions with bis-amines without requiring solvent or catalyst. A sub-set of the resultant materials were
readily water soluble and were investigated for antifungal activity in combination with the fungicide
iodopropynyl-butylcarbamate (IPBC) or the antifungal drug amphotericin B. The oligo-(b-aminoalcohol)s
alone were inactive against Trichoderma virens and Candida albicans but in combination with IPBC and
amphotericin B demonstrated synergistic growth-inhibition of both fungi. Quantitative analysis showed
that the presence of the terpene-based oligomers decreased the minimum inhibitory concentration
(MIC) of IPBC by up to 64-fold and of amphotericin B by 8-fold. The efficacy of the combined
formulation was further demonstrated with agar disk diffusion assays, which revealed that IPBC and
amphotericin B reduced the growth of the fungi, as shown by zones of inhibition, to a greater extent
when in the presence of the oligo-(b-aminoalcohol)s. These data suggest potential future use of these
renewable feedstock derived oligomers in antifungal material and related biomedical applications.
Introduction
Since their discovery in the early twentieth century, synthetic
polymers have been rapidly incorporated into almost every
aspect of modern life.1,2 In addition to large-scale uses in
clothing and packaging, synthetic polymers are increasingly
finding application in fields as diverse as electronics, high
performance structures and in medicine.1–4 Epoxide-based
polymers, first commercialised in the 1940s,5 have been parti-
cularly well-developed as a result of their excellent mechanical
strength, electrical insulation and thermal resistance.6 The
most common industrial use of epoxide-based polymers (‘epoxy
resins’) is in thermosetting materials and protective coatings.5
However, more recently, aliphatic epoxide systems have been
employed to produce materials with potential biomedical
applications. For example, Hamid et al. used epoxy–amine
polymerisations to form hydrogels as tissue engineering sup-
ports and drug delivery systems,7 while González Garcia et al.
formed epoxide-derived-networks with cycloaliphatic amines
which exhibited cytocompatibility properties suitable for use
in cardiovascular applications.8
The importance of epoxy resins can be gauged by their
global market size, which in 2015, was B$8 billion.9 These
materials account for a sizable part of the polymer industry, but
this is becoming increasingly problematic as almost all epoxy
polymers are petroleum-derived. Sustainability,10 along with
environmental11 and economic12 issues surrounding the use of
crude oil demand that new, renewable feedstocks are found for
polymer materials.
Research into renewable epoxy resin materials has examined
both the epoxide monomers as well as their curing agents.13
Investigations into alternative, bio-based monomers have
focused on synthesising bis-epoxides with similar structures
and properties to those of the most common counterparts
derived from crude oil:14 Xu et al. showed that certain cured
resins of de-polymerised Kraft and organosolv lignin showed
promise as a substitute for petroleum-based epoxy resins.15
Similarly, Caillol et al. developed a novel epoxy-monomer from
eugenol, a monolignol primarily found in cloves. When cured
with aliphatic and aromatic amines, the resins were found to
form thermosets with high glass transition temperatures and
good thermomechanical properties.10 These are only two exam-
ples as there is now a rapidly developing literature on the
synthesis of renewable epoxy resins from bio-based sources
such as lignin, rosin, tannins and sugars.16
Of the molecular biomass available, terpenes have generated
substantial interest as feedstocks for renewable polymers, with
numerous reviews on the subject.2,17,18 Terpenes are formed in
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a biosynthetic pathway common to a variety of trees, plants,
fungi and insects,19 are naturally abundant, and do not com-
pete directly with food sources, making them attractive renew-
able building blocks for a variety of applications.20 Terpenoids
are similar isoprene-based compounds that have incorporated
oxygen into their structures.21
Despite their abundance, monoterpenes have not been
explored to date in the generation of new monomers for
epoxy-resin chemistry. In this paper, we describe the synthesis
of a terpene-based epoxy monomer from (R)-carvone, a terpe-
noid found in caraway and spearmint oils in concentrations of
60% and 70–80%, respectively.22 While it can be extracted from
nature, (R)-carvone is also synthesised from limonene,22 a
terpene produced as a waste product of the citrus industry;
the (R)-enantiomer alone is produced on a scale of 70 kilotons
per annum.17 This, along with the functional groups of the
molecule, make (R)-carvone an attractive starting material for
the synthesis of a bis-epoxide monomer. We describe how an
epoxide monomer can be synthesised from (R)-carvone using
two parallel routes, and compare the conventional epoxidising
agent meta-chloroperbenzoic acid (mCPBA), with that of in situ
generated dimethyl dioxirane (DMDO) as electrophilic oxidis-
ing agents. For these reactions, we formed DMDO from the
reaction of Oxones in acetone, using conditions adapted from
those in the literature.23 We subsequently employed hydrogen
peroxide in a second step as a nucleophilic epoxidising agent.
These methods allowed for the synthesis of the bis-epoxide
monomer from a sustainable feedstock, using low hazard
oxidising agents and avoiding the use of chlorinated solvents.
We subsequently polymerised the epoxy-based monomers with
commercially available amines via simple step-growth, polyad-
dition reactions.7 The reaction did not require additional
components such as initiators or coupling agents, making it
appealing in terms of sustainability and any potential biome-
dical applications of the resulting materials.24 We further
demonstrated that the carvone-based bis-epoxide monomer
could undergo curing with a commercially available, di-
secondary diamine, also employing mild reaction conditions
with gentle heating.
With the overall aim of this study being to construct new,
renewable materials with suitable properties for use in biome-
dical or anti-biofouling applications, fungal inhibition by the
resulting oligomers was then investigated. The development of
new anti-fungal agents has encountered a number of chal-
lenges, including those of antifungal resistance.25–27 Synergis-
tic combinations of agents may offer a pragmatic approach to
this problem, as potent new formulations can be developed
without the need for specific new agents, and these approaches
may also be facilitated by repurposing known antifungals26,27
Additionally, synergistic combinations enable lower amounts
of active agents to be used.26 An anticipated membrane action
of the oligomers studied here supported the idea that it could
act synergistically with other inhibitory agents (discussed later).
We thus sought to investigate the use of our epoxy–amine
oligomers in synergistic antifungal treatments with the known
fungicide iodopropynyl butylcarbamate (IPBC) and the widely-
used antifungal amphotericin B, against the environmental
fungus Trichoderma virens (a common contaminant) and the
major human pathogen Candida albicans, respectively.
Experimental section
Materials
Commercially available chemical reagents were purchased
from Alfa Aesar, Acros Organics, Merck, Sigma Aldrich or
Fischer Scientific UK and used as received unless otherwise
stated. Solvents were purchased from Fischer Scientific UK and
used without further purification unless otherwise stated.
Water was deionised before use. Brine is a saturated aqueous
solution of sodium chloride. Solvent evaporation was per-
formed using a rotary evaporator under reduced pressure.
Reactions were monitored by TLC (Thin Layer Chromatogra-
phy) carried out on aluminium-backed plates coated with
Merck Kieselgel 60 F254, and visualised using KMnO4 stain
and gentle heating. Amphotericin B from Streptomyces sp. along
with fungicide 3-iodo-2-propynyl N-butylcarbamate, were pur-
chased from Sigma Aldrich. All compounds used in the anti-
fungal assays were prepared in DMSO, and added to growth
media to give the specified final concentrations.
General methods and instrumentation
Nuclear magnetic resonance. Bruker AV400 and AV3400
NMR spectrometers operating at 400 MHz (1H) and 101 MHz
(13C) at ambient temperature were used to perform nuclear
magnetic resonance (NMR) analysis in deuterated solvents.
Chemical shifts were assigned in parts per million (ppm).
1H NMR chemical shifts (dH) are reported with the shift of
CHCl3 (d = 7.26 ppm) as the internal standard when CDCl3 was
used. 13C chemical shifts (dC) are reported using the central line
of CHCl3 (d = 77.0 ppm) as the internal standard. All spectra
were obtained at ambient temperature (22  1 1C). MestReNova
6.0.2 copyright 2009 (Mestrelab Research S. L.) was used for
analysing the spectra.
Mass spectrometry. High Resolution Mass Spectrometry
(HRMS) was conducted using a Bruker MicroTOF spectrometer
operating in electrospray ionisation (ESI) mode.
Fourier-transform infra-red spectroscopy. FTIR spectroscopy
was performed in the range of 4000–650 cm1. This was carried
out using a Bruker Tensor 27 FT-IR spectrophotometer using an
ATR attachment. Spectra were analysed using MicroLab
software.
Gel permeation chromatography (GPC). Gel permeation
chromatography (GPC) was used for determination of number
average molecular weight (Mn), weight average molecular
weight (Mw), peak molecular weight (Mp) and molecular weight
distribution (polydispersity, Ð, Mw/Mn). The analysis was per-
formed using an Agilent 1260 Infinity Series HPLC (Agilent
Technologies, USA) fitted with a differential refractive index
detector (DRI). THF (HPLC grade, Fisher Scientific) was used as
eluent at room temperature using two Agilent PL-gel mixed-E
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columns in series at a flow rate of 1 mL min1. A calibration
curve was made using polycaprolactone standards.
Synthesis of a-epoxy-ketone, 1
To a solution of (R)-carvone (10.4 mL, 66.6 mmol) in MeOH (100
mL) was added 1 M NaOH solution (20 mL, 20.0 mmol) and
H2O2 (30% w/w, 8.4 mL, 80.0 mmol). The mixture was stirred
for 24 hours before quenching excess peroxides with sat. aq.
Na2S2O3 (100 mL). The aqueous layer was extracted with ethyl
acetate (2  100 mL) and the combined organic extracts were
washed with brine (2  100 mL) and dried over Na2SO4.
Volatiles were removed under reduced pressure and the pro-
duct was then concentrated in vacuo to afford the title com-
pound as a yellow oil (9.37 g; 85%) as a mixture of
diastereomers (9 : 1), only peaks for the major diastereomer
(1a) are reported.
Synthesis of bis-epoxide, 2, using mCPBA
To a solution of 1 (9.37 g, 56.47 mmol) in CH2Cl2 (100 mL) at
0 1C was added meta-chloroperbenzoic acid (mCPBA) (70% w/w,
16.7 g, 67.8 mmol) slowly over 10 minutes. The solution was
stirred for 16 hours at room temperature before excess per-
oxides were quenched with sat. aq. Na2S2O3 solution (100 mL).
The aqueous layer was then extracted with CH2Cl2 (100 mL) and
washed with NaHCO3 (3  150 mL), and brine (100 mL) before
drying over MgSO4. The solvent was removed under reduced
pressure to yield title compound as a mixture of diastereomers
as a yellow oil (yield: 8.82 g, 90%, dr = 9 : 9 : 1 : 1 2a : 2b : 2c : 2d,
i.e. (1R,4R,6R,7S) : (1R,4R,6R,7R) : (1S,4R,6S,7S) : (1S,4R,6S,7R)).
Only peaks for the two major diastereomers (2a and 2b) are
reported (see ESI† for further details).
Synthesis of bis-epoxide, 2, using Oxones
To a solution of 1 (3.715 g, 22.14 mmol) in acetone (90 mL) was
added NaHCO3 (8.95 g, 106.57 mmol). A solution of aqueous
Oxones was added (0.32 M, 106 mL) at a constant flow rate of 1
mL min1, at room temperature. After the addition, the aqu-
eous layer was extracted from the biphasic reaction medium
into diethyl ether (2  75 mL) and the combined organic
extractions were washed with brine (2  75 mL), dried over
MgSO4 and the solvent was removed under reduced pressure.
The bis-epoxide was isolated as a yellow oil consisting of a
mixture of diastereomers (yield: 4.47 g, 83%, dr = 9 : 9 : 1 : 1
2a : 2b : 2c : 2d, i.e. (1R,4R,6R,7S) : (1R,4R,6R,7R) : (1S,4R,6S,7S) :
(1S,4R,6S,7R)). As above, only peaks for the two major diaster-
eomers (2a and 2b) are reported (ESI†).
General procedure for the polymerisation of bis-epoxide, 2,
with secondary diamine, 3, to synthesise epoxy–amine
oligomers, 4
To a glass vial of 2 (3.47 mmol, 0.632 g) was added 1,6-dimethyl
hexane-1,6-diamine (3) (3.47 mmol, 0.62 mL). The mixture was
heated to the appropriate temperature for the given length of
time to yield a viscous, dark-brown oil. Further details of the
syntheses (conditions, times, temperatures) are provided in the
ESI.†
Fungal growth inhibition assays
For growth assays with Candida albicans SC5314, a standard
laboratory strain, single colonies from YPD agar plates were
used to inoculate YPD broth cultures [2% peptone (Oxoid,
Basingstoke, UK), 1% yeast extract (Oxoid), 2% D-glucose] in
Erlenmeyer flasks and incubated overnight at 37 1C with orbital
shaking at Q5120 rpm. Overnight cultures were diluted to OD600
B 0.5 and cultured for a further 4 hours in fresh medium. The
4 hour mid/late exponential cultures were diluted to OD600 B
0.01 and 100 mL aliquots transferred to 96-well microtiter plates
(Greiner Bio-one; Stonehouse, UK), with drugs and oligomer
added to final concentrations as specified in the Results sec-
tion. Plates were incubated at 37 1C with shaking in a BioTek
Powerwave XS microplate spectrophotometer and OD600 was
recorded every 30 min. For growth assays with Trichoderma
virens CBS 430.54, spores were harvested from 7 d PDA (Oxoid)
plates and inoculated to PDB (Sigma-Aldrich) broth to a
concentration of 15 000 spores per mL. Aliquots (100 mL) of
the diluted culture plus any chemical supplements, as specified
in the Results section, were transferred to 96-well plates and
cultured statically for up to 65 hours at 30 1C in a BioTek
Powerwave XS microplate spectrophotometer. For assaying
antifungal combinations, concentrations of agents used were
those determined from preliminary assays to be just sub-
inhibitory or slightly inhibitory when supplied individually.
Checkerboard assays
General culturing and preparation for yeast ‘checkerboard’
assays was according to EUCAST guidelines.28 Briefly, yeast
cells from single colonies were inoculated from 2-d PDA plates
to RPMI 1640 medium + 2% glucose and cell concentration
adjusted to a final inoculum of 105 cells per mL. All culturing
for checkerboard assays with T. virens was as described above.
Culture aliquots (100 mL) were transferred to 96-well microtiter
plates with chemicals added at the concentrations specified in
the checkerboard figures (below). The inoculated plates were
incubated statically for 48 hours at 30 1C (T. virens) or 24 hours
at 37 1C (C. albicans). OD600 was then measured with a BioTek
EL800 microplate spectrophotometer. Fractional Inhibitory
Concentration (FIC) as an indicator of synergy was calculated as
described.29
Disk diffusion assays
PDA and YPD medium were inoculated with 106 spores per mL
(T. virens) from 7 d-PDA plates and 107 cells per mL from
exponential growth-YPD broth cultures (C. albicans), respec-
tively. Sterile Whatman paper filter disks loaded with 10 mL
inhibitor(s) were laid on the plates and incubated at 30 1C for
48 hours (T. virens) or at 37 1C for 24 hours (C. albicans).
Results and discussion
Synthesis of bis-epoxide monomer, 2
Two parallel routes towards the synthesis of a carvone-based
bis-epoxide monomer were designed, through the sequential
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epoxidations of the double-bonds in the molecule (Scheme 1).
These double bonds are electronically distinct from one
another,30 which gives rise to the regioselective epoxidation at
either the endo- or exocyclic positions.30 The endocyclic double
bond is electron deficient due to its conjugation with the
ketone, so epoxidation at this position was achieved using
alkaline hydrogen peroxide, which reacts as a nucleophilic
oxidising agent. The a-epoxy ketone (1) was obtained in 90%
yield, in a diastereomeric ratio of 9 : 1 for the epoxide in the
(R,R) : (S,S) positions, i.e. 1a and 1b, (Scheme 1), respectively.
The diastereomeric ratio was determined using 1H NMR
spectroscopy, according to the integration of the resonances
corresponding to the methyl group in the a-position to the
carbonyl moiety. The peak positions for these shifts are found
at 1.70 ppm and 1.69 ppm for 1a and 1b, respectively. The
stereochemical selectivity displayed in this reaction is thought
to be a result of the formation of the more favourable chair-like
transition state via axial attack of the hydroperoxide anion. In
this reaction, the exocyclic alkene remained completely
intact.31
The mixture of a-epoxy ketones 1a and 1b was then treated
with mCPBA to oxidise the electron-rich, exocyclic alkene. No
stereoselectivity was observed in this reaction, resulting in a
mixture of bis-epoxide species 2a to 2d in a 90% yield
(Scheme 1, route 1). By this route, the monomer was thus
synthesised in a two-step process with an overall yield of 81%,
in a diastereomeric ratio of 9 : 9 : 1 : 1. It was found that epox-
idising the double bonds in the reverse order, i.e. the exocyclic
double bond first with mCPBA, followed by the endocyclic one
with H2O2, brought about the same results in similar yields and
diastereomeric ratios; we did not find either sequence to have a
distinct advantage over the other. Attempts to use mCPBA to
bring about the epoxidation of both double bonds in one step
were not successful.
The use of mCPBA is not atom economic and produces a
biproduct, chloroperbenzoic acid, as stoichiometric waste. The
reaction is also very exothermic, a particular issue when work-
ing at a large scale, and makes use of dichloromethane, a
suspected carcinogen. To avoid the use of this reagent, an
alternative synthesis was designed, using dimethyl dioxirane
as the oxidant. This can be made in situ from the reaction of
acetone and Oxones, the commercial name for potassium
peroxymonosulfate, an inexpensive, stable salt.23 This method
avoids the use of metal catalysts, is cheap, and the organic
product can be easily isolated without the use of chlorinated
solvents, or the need for further purification.23
When the mixture of a-epoxy ketones 1a and 1b was treated
with Oxones in acetone, the bis-epoxide monomer species 2a
to 2d were produced in a yield of 83%, resulting in an overall
yield over the two steps of 75% (Scheme 1, route 2). This is
comparable to the mCPBA route, and as such the Oxones route
can be considered the most advantageous as it significantly
improves the sustainability of the monomer synthesis. As with
mCPBA, attempts to synthesise the bis-epoxide monomer in
one step using Oxones were not successful.
We were not concerned with isolating the monomer as a
pure diastereomer and did not attempt to separate or isolate
the mixture of diastereomers of either 1 or 2. For simplicity, the
stereochemistry is not represented in this article.
Synthesis of epoxy–amine oligomer 4, with bis-epoxide 2 and
secondary diamine 3
Typically, the reaction of a bis-epoxide and a diamine curing
agent is known to proceed at ambient temperature32 and in the
absence of coupling agents or initiators.7 Curing is usually
performed with primary or secondary di- or poly-amines.33
These may be aliphatic, cycloaliphatic or aromatic.6 Following
the synthesis of the terpene-based bis-epoxide monomer 2, its
step-growth polymerisation was investigated by reaction with
the commercially available, aliphatic, di-secondary diamine,
N1,N6-dimethylhexane-1,6-diamine, 3 (Scheme 2). This diamine
was specifically chosen as it features a relatively long, flexible
hexyl linker, which was anticipated would minimise the possi-
bility of intra-molecular cyclisation. Initially, the monomers
were mixed together in a 1 : 1 ratio, in the absence of solvent or
catalyst, and heated to temperatures ranging from 0 1C to
110 1C, for 5 hours using an oil bath. NMR analyses indicated
that samples conducted from 0 1C to 50 1C returned the two
monomers, without any reaction. However, for samples con-
ducted from 70 1C to 110 1C, it was evident by NMR and IR
analysis that the reaction had proceeded, and no further trace
of the bis-epoxide monomer could be detected by 1H NMR
(Fig. 1A). GPC analysis indicated the formation of populations
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Scheme 1 Synthesis of bis-epoxide monomer (2) via epoxidation using alkaline hydrogen peroxide followed by either mCPBA (route 1) or Oxones
(route 2).
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of short-chain oligomers for samples conducted Z70 1C
(Fig. 1B).
A range of experimental conditions were tested in attempts
to control the molar masses of the samples, including tem-
peratures of 22 1C, 50 1C, 70 1C and 90 1C, and reaction times of
24 hours, 4/5 days and 7 days. By GPC analysis, it was evident
that curing times of 24 hours led to the formation of small
populations of oligomers with increased molar mass, relative to
those conducted at the same temperature for only 5 hours.
Longer times of up to one week were required to increase
sufficiently the mass fractions of these populations (Fig. 1C).
In each case, longer reaction times combined with higher
temperatures increased the viscosity of the samples, to the
point at which the vials could be inverted without any move-
ment of the sample. These samples were also less soluble in a
variety of solvents than their counterparts conducted over only
5 hours. It is unlikely that the polymer chains cross-linked
during the curing process, as, when considering the base-
catalysed mechanism for ring-opening of epoxides, each sec-
ondary amine becomes tertiary after just a single addition to an
epoxide. Additionally, the hydroxyl groups formed are predicted
to be tertiary, and therefore unlikely to undergo nucleophilic
attack. While the alternative, acid-catalysed mechanism would
produce a primary and secondary alcohol which would be able
to crosslink, we anticipate that this product was unlikely to
form in these conditions, due to the presence of the basic di-
amine monomer. As such, cross-linking via the predicted
tertiary hydroxyl groups was not considered further.
As the ratio of epoxide to amine was kept strictly at 1 : 1,
minimal cross-linking would occur between the end-groups of
the oligomers, and so the difference in viscosity were most
likely caused by increased proportions of higher mass-fractions
of the populations of oligomers present, with those with higher
amounts of higher-mass populations inducing more viscous
properties to the overall sample. NMR spectra for the samples
were consistent, but were complex, and were not diagnostic in
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Fig. 1 1H NMR spectrum showing complete conversion of bis-epoxide monomer to cured oligomers (A), GPC chromatogram indicating the presence of
short-chain oligomers in samples conducted Z70 1C (B), and GPC chromatogram indicating the effect of time on the mass-fraction of short-chain
oligomers with higher Mn (C).
Scheme 2 Synthesis of epoxy/amine oligomers.
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determining chain length in each sample. However, NMR
spectra were able to confirm that the monomers had been
consumed, as evident through the depletion of the resonance
corresponding to the proton in the alpha-position to the
endocyclic epoxide (Fig. 1A). This was the less-hindered posi-
tion for reaction of the epoxides with the secondary amines,
and the most favourable under basic conditions, and thus was
the expected position for nucleophilic addition at the cyclo-
hexyl ring. Data from the GPC analysis indicated the oligomers
formed were approximately 500 Da, with polydispersities ran-
ging from 1.2–1.3, which is within the expected range for a
polyaddition mechanism (see ESI† for specifics).
Further analogous polymerisations were conducted with
hexane-1,6-diamine, as a structurally similar monomer, but
with 2 primary amines rather than the 2 secondary amines of
N1,N6-dimethylhexane-1,6-diamine. The bis-epoxide monomer
2 was subject to the same curing conditions as described for the
secondary-amine, above, and the reaction was found to proceed
to form hard, glassy materials, indicative of possible cross-
linking at the amine moieties. These materials were found to be
insoluble in water, DMSO and a variety of non-polar solvents,
confirming the likelihood of cross-linking. Considering the
need for aqueous solubility in our formulations, we therefore
did not investigate further the potential anti-fungal activity of
these oligomers.
Growth inhibition and checkerboard assays
Synergistic activity of the oligomers of 4 with the antifungal
drug amphotericin B and the fungicide iodopropynyl butylcar-
bamate (IPBC) were investigated against Candida albicans and
Trichoderma virens, respectively (Fig. 2).
Amphotericin B is a polyene antifungal which has proven
activity against Candida species.34 It binds to sterols leading to
the formation of pores in the cell membrane, which allows
leakage of cellular components, ultimately resulting in death of
the fungus.35 However, amphotericin B is also nephrotoxic,
which limits its use to doses of between 3–5 mg kg1,35 and
attempts to overcome this have been limited both in terms of
cost of the treatment, and its effectiveness.34 A synergistic
therapy therefore presents an attractive possibility for treat-
ment of Candida species with this drug.
To investigate the synergistic activity of 4 with amphotericin
B against C. albicans, first the compounds were supplied at sub-
inhibitory concentrations in YPD medium (1.25 mg mL1
oligomer and 4 mg mL1 drug; sub-inhibitory concentrations
and MICs were determined in preliminary assays; note, inhibi-
tory amphotericin B concentrations are higher in rich YPD
medium than in RPMI used for checkerboard assays below).
When combined, these compounds produced a complete inhi-
bition of the growth of the fungus in YPD (Fig. 3A). Standard
‘checkerboard’ analyses in RPMI medium showed that the
combination decreased the minimum inhibitory concentration
(MIC) for amphotericin B by 8-fold, from 1 mg mL1 to 0.13 mg
mL1 (Fig. 3B) (the MIC for 4, individually, was 2.5 mg mL1).
The fractional inhibitory concentration (FIC) was calculated to
be 0.16 indicating a synergistic effect as combinations are
normally considered synergistic when FIC r 0.5.36 We also
investigated the activity of amphotericin B with the two mono-
mers 2 and 3 and found by checkerboard analysis that neither
of these exhibited synergistic effects as with 4 (Fig. 3B). The
FICs were 0.62 for drug combined with the bis-epoxide 2, and
1.0 for drug combined with the diamine 3 (MICs for these
monomers were 5.0 and 2.5 mg mL1 respectively).
We further illustrated the synergistic relationship by means
of an agar disk diffusion assay (Fig. 3C). Sterile filter paper
1
5
10
15
20
25
30
35
40
45
50
55
1
5
10
15
20
25
30
35
40
45
50
55Fig. 2 The structures of iodopropynyl butylcarbamate (IPBC) and ampho-
tericin B.
Fig. 3 Data obtained from investigations into the antifungal activity of 4
with amphotericin B against C. albicans: oligomer 4 acts in synergy with
amphotericin B against Candida albicans. C. albicans was cultured in YPD
in the presence of 4 and/or amphotericin B supplied at the indicated sub-
inhibitory concentrations. The values are means  SEM from three
replicate experiments (A). Checkerboard analysis performed in RPMI
indicating the synergistic antifungal relationship between 4 and ampho-
tericin B against C. albicans (FIC = 0.16), with no synergy evident between
amphotericin B and either of the monomers 2 and 3 (FIC = 0.62 and 1.0,
respectively). The values are means from three replicate experiments. (B)
The susceptibility of C. albicans to 4 in combination with amphotericin B
(AmB) was also tested by agar disk diffusion assay on YPD agar. Inhibition
zones were observed after 24 hours (C).
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disks were soaked with the inhibitors and laid on agar plates
inoculated with C. albicans. The susceptibility of the fungus
after 24 hours to the combination of 4 with amphotericin B was
evident by zones of inhibition which were greater with the
agents combined than by a simple product of their individual
effects at the same doses.
Unlike C. albicans, Trichoderma virens is not pathogenic to
humans. However, fungicidal treatments against Trichoderma
virens are valuable for materials applications, for example, in
protecting paints, sealants or coatings from fungal colonisa-
tion. The synergistic activities of the oligomers of 4 against T.
virens were investigated together with IPBC, which is widely
used in the cosmetics industry and as a preservative in paint-
ing, textiles and adhesives.37,38 However, its use has also caused
allergic reactions and thus there is a need to reduce the levels of
IBPC incorporation in formulations for more widespread
applications.37
A growth inhibition assay was conducted with compounds
provided at sub-inhibitory concentrations, as done above with
C. albicans. When combined in this way, 4 and IPBC produced a
complete inhibition of fungal growth (Fig. 4A). Checkerboard
analyses were again used and these indicated (Fig. 4B) syner-
gistic antifungal activity between the oligomers of 4 and IPBC.
The presence of just 250 mg mL1 of 4 was found to decrease
the MIC of IPBC by up to 64-fold, from 1600 ng mL1 to 25 ng
mL1. The FIC for the combination was found to be 0.37,
indicating a synergistic relationship.36 Synergy was also
observed for the two monomers (FIC = 0.31 and 0.38 for 2
and 3, respectively). However, MICs of 4.5 mg mL1 (2) and 1.8
mg mL1 (3) were found for these small molecules, highlight-
ing the advantage of the oligomeric system which required
much less material as the MIC of 4 was only 0.5 mg mL1. The
evidence for a synergistic relationship in activity for IBPC and
the oligo-(b-aminoalcohol) 4 was supported by means of a disk
diffusion assay: sterile filter paper disks were soaked with the
inhibitors and laid on agar plates inoculated with T. virens. Two
concentrations of IPBC, 25 mg mL1 and 50 mg mL1, were
inoculated alongside 0 mg mL1 and 100 mg mL1 of the
oligomers. The susceptibility of T. virens to the combination of
4 with IPBC was visually evident by zones of inhibition, which
could be observed after 48 hours (Fig. 4C). The anti-fungal
relationship was, as expected, more evident with the higher
doses of both the fungicide and 4.
The potential mechanisms underlying the synergistic activ-
ity of the antifungal agents and oligo-(b-aminoalcohol) 4 are
likely to involve interactions of the compounds with fungal
membranes. Oligomer 4 contains tertiary amine groups, H-
bonding hydroxyls and also a degree of lipophilicity from the
substituted hexane repeat units. As a consequence, the oligo-
mers were probably partially charged at the pH values of the
assays and thus amphiphilic. It has been well-established that a
degree of membrane activity from amphiphilic components
can enhance the efficacy of anti-fungal agents,39 and it has also
been very recently shown that polycations such as poly(lysine)
and DEAE dextran hydrochloride have membrane-disrupting
effects on C. albicans.40 Since it has also been established that
polycations induce leakage of cell contents in yeasts,41 we think
it possible that the synergy we observed with 4 and IBPC and
Amp B arose due to a combination of membrane disruption
and conventional antifungal activity. The cell walls of fungi
contain multiple glycoproteins and polysaccharides, but vary
not only with the specific fungal strain but also with the
environment in which the fungi inhabit. It is therefore challen-
ging to ascribe specific anti-fungal membrane effects to com-
ponents in a formulation without a systematic evaluation of
each individual component under well-defined conditions.
However, we are currently preparing further derivatives of these
oligomers with a view to testing the membrane activity hypoth-
esis and will report these data in a future manuscript.
Conclusions
In this study we have successfully synthesised a bis-epoxide
monomer from a renewable terpene feedstock, in high yield
over two steps. We have shown that this can be achieved using
inexpensive chemistry and under mild conditions, and have
eliminated the need for mCPBA. This monomer was then used
in a step-growth polyaddition mechanism with a commercially
available, aliphatic, secondary diamine using well-established
epoxy–amine chemistry. In the absence of catalysts or solvents,
this reaction was found to produce populations of low mole-
cular weight oligomers. While optimisation of this poly-
merisation might be useful to investigate a higher conversion
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Fig. 4 Oligomer-4 acts in synergy with IPBC against Trichoderma virens.
T. virens was cultured in PDB in the presence or absence of 4 in
combination with IPBC at the indicated sub-inhibitory concentrations.
The values are means  SEM from three replicate experiments (A).
Checkerboard analysis indicating the synergistic antifungal relationship
against T. virens between 4 (MIC = 0.5 mg mL1) and IPBC, and moderate
synergistic relationship between IPBC and monomers 2 and 3, respec-
tively. The values are means from three replicate experiments (B). The
susceptibility of T. virens to 4 in combination with IPBC was also tested by
agar disc diffusion assay. Inhibition zones were observed after 48 hours
(C).
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of these oligomers to longer chain polymers, the shorter-chain
materials were found to have suitable properties for use in
antifungal applications: the oligomer 4 was found to act in
synergy with known fungicide IPBC and the antifungal drug
amphotericin B against Trichoderma virens and Candida albi-
cans, respectively. This was demonstrated using growth inhibi-
tion assays, checkerboard assays, and disk diffusion assays. In
the case of both fungi, the addition of the oligomers of 4 was
found to reduce the MIC of the respective antifungal agent.
These can be considered positive preliminary results for the
future use of these oligomers in antifungal material and
biomaterial applications.
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J. A. Lopez-Sanchez and M. Pagliaro, Chem. Commun.,
2014, 50, 15288–15296.
19 M. Belgacem and A. Gandini, in Monomers, Polymers and
Composites from Renewable Resources, ed. M. Naceur Belga-
cem and A. Gandini, Elsevier Ltd, Oxford, 1st edn, 2008,
pp. 17–38.
20 M. Thomsett, J. C. Moore, A. Buchard, R. Stockman and
S. M. Howdle, Green Chem., 2019, 21, 149–156.
21 IUPAC, Compendium of Chemical Terminology (the ‘Gold
Book’), IUPAC, 2.3.3., 1997.
22 G. Reuss, W. Disteldorf, A. O. Gamer and A. Hilt, Ulmann’s
Encycl. Ind. Chem., 2012, vol. 15, pp. 735–768.
23 L. Charbonneau, X. Foster and S. Kaliaguine, ACS Sustain-
able Chem. Eng., 2018, 6, 12224–12231.
24 Z. A. A. Hamid, A. Blencowe, B. Ozcelik, J. A. Palmer,
G. W. Stevens, K. M. Abberton, W. A. Morrison,
A. J. Penington and G. G. Qiao, Biomaterials, 2010, 31,
6454–6467.
25 A. Chen, H. Peng, I. Blakey and A. K. Whittaker, Polym. Rev.,
2017, 57, 276–310.
26 C. Vallières, R. Raulo, M. Dickinson and S. V. Avery, Front.
Microbiol., 2018, 9, 1–15.
27 E. Moreno-Martinez, C. Vallieres, S. L. Holland and
S. V. Avery, Sci. Rep., 2015, 5, 1–11.
28 M. C. Arendrup, et al., EUCAST antifungal MIC method for
yeasts, 2017, vol. 7.3.1, pp. 1–21.
29 M. H. Hsieh, C. M. Yu, V. L. Yu and J. W. Chow, Diagn.
Microbiol. Infect. Dis., 1993, 16, 343–349.
30 K. K. W. Mak, Y. M. Lai and Y.-H. Siu, J. Chem. Educ., 2006,
83, 1058.
1
5
10
15
20
25
30
35
40
45
50
55
1
5
10
15
20
25
30
35
40
45
50
55
8 | J. Mater. Chem. B, 2019, 00, 19 This journal is c The Royal Society of Chemistry 2019
Paper Journal of Materials Chemistry B
31 J. Clayden, N. Greeves and S. Warren, Organic Chemistry,
Oxford University Press, Oxford, 2nd edn, 2012.
32 F. L. Jin, X. Li and S. J. Park, J. Ind. Eng. Chem., 2015, 29,
1–11.
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